These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8541241)

  • 1. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
    Schoonen WG; Joosten JW; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):439-44. PubMed ID: 8541241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
    Schoonen WG; Joosten JW; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):423-37. PubMed ID: 8541240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of progestagens and Org OD14 in in vitro and in vivo tumor models.
    Kloosterboer HJ; Schoonen WG; Deckers GH; Klijn JG
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):311-8. PubMed ID: 8043494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH; Parker CJ; Jordan VC
    Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
    Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
    Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D.
    Hissom JR; Bowden RT; Moore MR
    Endocrinology; 1989 Jul; 125(1):418-23. PubMed ID: 2737155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
    Jeng MH; Jordan VC
    Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
    Schneck H; Ruan X; Seeger H; Cahill MA; Fehm T; Mueck AO; Neubauer H
    Gynecol Endocrinol; 2013 Feb; 29(2):160-3. PubMed ID: 23116217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions.
    van der Burg B; Kalkhoven E; Isbrücker L; de Laat SW
    J Steroid Biochem Mol Biol; 1992 Jun; 42(5):457-65. PubMed ID: 1616875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines.
    Savoldi G; Ferrari F; Ruggeri G; Sobek L; Albertini A; Di Lorenzo D
    Int J Biol Markers; 1995; 10(1):47-54. PubMed ID: 7629427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
    Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
    Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
    Gill PG; Vignon F; Bardon S; Derocq D; Rochefort H
    Breast Cancer Res Treat; 1987 Oct; 10(1):37-45. PubMed ID: 3689980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.